De-escalation of treatment for acute promyelocytic leukaemia?

被引：1

作者：

Mathews, Vikram ^{[1
]}

机构：

[1] Christian Med Coll & Hosp, Dept Haematol, Vellore 632004, Tamil Nadu, India

来源：

LANCET HAEMATOLOGY | 2015年 / 2卷 / 09期

关键词：

TRANS-RETINOIC ACID; ARSENIC TRIOXIDE;

D O I：

10.1016/S2352-3026(15)00129-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E348 / E349

页数：2

共 9 条

[1] Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid [J].

Estey, E ;

Koller, C ;

Cortes, J ;

Reed, P ;

Freireich, E ;

Giles, F ;

Kantarjian, H .

LEUKEMIA & LYMPHOMA, 2001, 42 (03) :309-316

[2] All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4) [J].

Iland, Harry J. ;

Bradstock, Ken ;

Supple, Shane G. ;

Catalano, Alberto ;

Collins, Marnie ;

Hertzberg, Mark ;

Browett, Peter ;

Grigg, Andrew ;

Firkin, Frank ;

Hugman, Amanda ;

Reynolds, John ;

Di Iulio, Juliana ;

Tiley, Campbell ;

Taylor, Kerry ;

Filshie, Robin ;

Seldon, Michael ;

Taper, John ;

Szer, Jeff ;

Moore, John ;

Bashford, John ;

Seymour, John F. .

BLOOD, 2012, 120 (08) :1570-1580

[3]

Iland HJ, 2015, LANCET HAEMATOL

[4] Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry [J].

Lehmann, S. ;

Ravn, A. ;

Carlsson, L. ;

Antunovic, P. ;

Deneberg, S. ;

Mollgard, L. ;

Derolf, A. Rangert ;

Stockelberg, D. ;

Tidefelt, U. ;

Wahlin, A. ;

Wennstrom, L. ;

Hoglund, M. ;

Juliusson, G. .

LEUKEMIA, 2011, 25 (07) :1128-1134

[5] Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia [J].

Lo-Coco, F. ;

Avvisati, G. ;

Vignetti, M. ;

Thiede, C. ;

Orlando, S. M. ;

Iacobelli, S. ;

Ferrara, F. ;

Fazi, P. ;

Cicconi, L. ;

Di Bona, E. ;

Specchia, G. ;

Sica, S. ;

Divona, M. ;

Levis, A. ;

Fiedler, W. ;

Cerqui, E. ;

Breccia, M. ;

Fioritoni, G. ;

Salih, H. R. ;

Cazzola, M. ;

Melillo, L. ;

Carella, A. M. ;

Brandts, C. H. ;

Morra, E. ;

von Lilienfeld-Toal, M. ;

Hertenstein, B. ;

Wattad, M. ;

Luebbert, M. ;

Haenel, M. ;

Schmitz, N. ;

Link, H. ;

Kropp, M. G. ;

Rambaldi, A. ;

La Nasa, G. ;

Luppi, M. ;

Ciceri, F. ;

Finizio, O. ;

Venditti, A. ;

Fabbiano, F. ;

Doehner, K. ;

Sauer, M. ;

Ganser, A. ;

Amadori, S. ;

Mandelli, F. ;

Doehner, H. ;

Ehninger, G. ;

Schlenk, R. F. ;

Platzbecker, U. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :111-121

[6] Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data [J].

Mathews, Vikram ;

George, Biju ;

Chendamarai, Ezhilarasi ;

Lakshmi, Kavitha M. ;

Desire, Salamun ;

Balasubramanian, Poonkuzhali ;

Viswabandya, Auro ;

Thirugnanam, Rajashekar ;

Abraham, Aby ;

Shaji, Ramachandran Velayudhan ;

Srivastava, Alok ;

Chandy, Mammen .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) :3866-3871

[7] Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].

Shen, ZX ;

Chen, GQ ;

Ni, JH ;

Li, XS ;

Xiong, SM ;

Qiu, QY ;

Zhu, J ;

Tang, W ;

Sun, GL ;

Yang, KQ ;

Chen, Y ;

Zhou, L ;

Fang, ZW ;

Wang, YT ;

Ma, J ;

Zhang, P ;

Zhang, TD ;

Chen, SJ ;

Chen, Z ;

Wang, ZY .

BLOOD, 1997, 89 (09) :3354-3360

[8]

Wang Z Y, 2000, Lancet Oncol, V1, P101, DOI 10.1016/S1470-2045(00)00017-6

[9] All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis [J].

Zhu, Hongming ;

Hu, Jiong ;

Li, Xiaoyang ;

Chen, Li ;

Zhao, Huijin ;

Zhou, Wei ;

Wang, Lining ;

Zhao, Xia ;

Zhang, Yunxiang ;

Chen, Yu ;

Sun, Huiping ;

Chen, Qiusheng ;

Chen, Yu ;

Zhao, Weili ;

Mi, Jianqing ;

Shen, Zhixiang ;

Chen, Zhu ;

Wang, Zhenyi ;

Li, Junmin ;

Chen, Saijuan .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (02) :277-280

← 1 →